Invention Grant
US08507547B2 Anti-fatigue agents and oral compositions containing andrographolide as active ingredient
有权
含有穿心莲内酯作为活性成分的抗疲劳剂和口服组合物
- Patent Title: Anti-fatigue agents and oral compositions containing andrographolide as active ingredient
- Patent Title (中): 含有穿心莲内酯作为活性成分的抗疲劳剂和口服组合物
-
Application No.: US12602006Application Date: 2008-05-30
-
Publication No.: US08507547B2Publication Date: 2013-08-13
- Inventor: Sumio Asami , Kayo Saito , Akifumi Maeda , Norifumi Tateishi
- Applicant: Sumio Asami , Kayo Saito , Akifumi Maeda , Norifumi Tateishi
- Applicant Address: JP Osaka-shi, Osaka
- Assignee: Suntory Holdings Limited
- Current Assignee: Suntory Holdings Limited
- Current Assignee Address: JP Osaka-shi, Osaka
- Agency: Drinker Biddle & Reath LLP
- Priority: JP2007-144623 20070531
- International Application: PCT/JP2008/060011 WO 20080530
- International Announcement: WO2008/149802 WO 20081211
- Main IPC: A01N43/02
- IPC: A01N43/02 ; A01N43/08 ; A61K31/335 ; A61K31/34
Abstract:
Disclosed is a composition which is safe for a human body and an animal, can be ingested continuously on a daily basis, has an anti-fatigue activity, and is effective for the prevention or treatment of a disease or condition associated with fatigue. Specifically disclosed is an anti-fatigue agent comprising andrographolide optionally together with an α-lipoic acid as an active ingredient(s). Also disclosed is a novel oral composition comprising andrographolide and an α-lipoic acid. The anti-fatigue agent and the oral composition are useful for the prevention or treatment of chronic fatigue syndrome, overfatigue, physical fatigue, mental fatigue and organ fatigue.
Public/Granted literature
- US20100144866A1 ANTI-FATIGUE AGENTS AND ORAL COMPOSITIONS CONTAINING ANDROGRAPHOLIDE AS ACTIVE INGREDIENT Public/Granted day:2010-06-10
Information query
IPC分类:
